Deeper Knowledge, Faster

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Johnson and Johnson
US Army
Mallinckrodt
Chinese Patent Office
Queensland Health
Cerilliant
Julphar
Colorcon
Deloitte

Generated: January 19, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,643,602

« Back to Dashboard

Summary for Patent: 5,643,602
Title: Oral composition for the treatment of inflammatory bowel disease
Abstract:An oral pharmaceutical composition is described for targeted slow release in the treatment of inflammatory bowel diseases. Also described are pharmaceutical compositions for peroral treatment targeted to different areas of the intestinal tract afflicted by ulcerative colitis and certain aspects of Crohn's disease.
Inventor(s): Ulmius; Jan (Lund, SE)
Assignee: Astra Aktiebolag (Sodertalje, SE)
Application Number:08/240,078
Patent Claim Types:
see list of patent claims
Use; Formulation; Dosage form; Composition; Process;

Drugs Protected by US Patent 5,643,602

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 5,643,602

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Sweden8903914Nov 22, 1989

International Patents Family Members for US Patent 5,643,602

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Israel 96415 ➤ Subscribe
Egypt 19642 ➤ Subscribe
European Patent Office 0502092 ➤ Subscribe
Spain 2074698 ➤ Subscribe
Finland 922325 ➤ Subscribe
Finland 104949 ➤ Subscribe
Finland 991893 ➤ Subscribe
Greece 3017691 ➤ Subscribe
Hong Kong 51897 ➤ Subscribe
Croatia P920632 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Novartis
QuintilesIMS
Healthtrust
Cerilliant
Cantor Fitzgerald
Fish and Richardson
AstraZeneca
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot